Huons Global Obtains Product Approval for Liztox Injection Targeting Eye Wrinkles
[Asia Economy Reporter Ji Yeon-jin] Huons Global announced on the 27th that its botulinum toxin-based treatment, Riztox Injection 100 Units, has received product approval from the Ministry of Food and Drug Safety for the treatment of crow's feet.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Previously, the product was approved only for the treatment of glabellar lines, but this approval expands its indication to include the treatment of crow's feet.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
